Where does Megaforce Company Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Megaforce Company Limited ranks #29,421 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Megaforce Company Limited hold?

Megaforce Company Limited holds 9 US utility patents granted between 2016 and 2024, spanning 9 technology areas.

What is Megaforce Company Limited's Innovation Score?

Megaforce Company Limited has an Innovation Score of 29.2 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Megaforce Company Limited focus on?

Megaforce Company Limited's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 4 patents, ranking #3,645 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Megaforce Company Limited's patent grant rate increasing or decreasing?

Megaforce Company Limited's recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Megaforce Company Limited's patents?

Megaforce Company Limited's patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Megaforce Company Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Megaforce Company Limited

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Megaforce ranks #29,421 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#29,421
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.2/100): 12.1
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29421 · Foreign Corporation #29,421 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,421/49,997
PHOTO-FINISH Medicines360
CPC-NARROW A61B · 9 areas
INNOV-THIN 29.2/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medicines360 (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Megaforce’s 29.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (27%) Velocity 3.3 pts (11%) Breadth 10.6 pts (36%) Claim depth 7.3 pts (25%)

Qualcomm Incorporated · highest

85
Megaforce · this assignee

29
3D Lighting… · lowest

7

What this shows Megaforce's Innovation Score is 29.2/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Megaforce?

Each dot is one of Megaforce’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Megaforce’s own 12.1 claims/patent is at or below the 14.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Megaforce vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Megaforce's grants concentrate

Megaforce Company Limited is a focused PatentsView assignee: 9 CPC subclasses with 44.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2016. By volume, Megaforce sits between Medicines360 and Mems Start, LLC.

Megaforce's three-year grant acceleration

Megaforce Company Limited shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Medicines360

9
Medspray B V

9
MEG Energy

9
Mega1

9
Mekorot Water

9
Melchior Material…

9
Melrok

9
Mems Start

9
Megaforce ◀

9

What this shows Megaforce holds 9 patents at rank #29,369, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Megaforce

By rank, the assignees closest to #29,369 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Megaforce's primary technology class.

Megaforce's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Megaforce Company Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	11.1%
2018	2	22.2%
2019	3	33.3%
2020	1	11.1%
2024	2	22.2%

Which technologies does Megaforce Company Limited patent most?

A61B - DIAGNOSIS; SURGERY; Identification 4

G02B - Optical Elements, Systems OR Apparatus 4

H04N - Pictorial Communication, e.g. Television 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

G03B - Apparatus OR Arrangements FOR Taking Photographs OR FOR Projecting OR Viewing THEM; Apparatus OR Arrangements Employing Analogous Techniques Using Waves Other Than Optical WAVES; Accessories Therefor 2

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 1

G06F - Electric Digital Data Processing 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Megaforce Company Limited's patent record in context - here's where to go next.

Megaforce Company Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 44.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #29,421 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Megaforce Company Limited against Medicines360, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.